Colorectal Adenocarcinoma: From Pathophysiology to Novel Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 3084
Special Issue Editors
Interests: colorectal cancer; low anterior resection syndrome; minimally invasive surgery; microbiota in colon and rectum
Interests: colorectal cancer; low anterior resection syndrome; minimally invasive surgery; microbiota in colon and rectum
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) is the third most diagnosed cancer and a leading cause of cancer-related death worldwide. For the past several decades, significant progress in its molecular pathogenesis has led to precise treatment and patient management.
Recently, knowledge regarding pathogenesis of colorectal cancer has grown, but it is still limited. Understanding the underlying molecular mechanisms of CRC is essential to improve early diagnosis and patient-tailored treatment. Furthermore, the unique clinicopathologic features and risk factors of CRC are not well defined yet. There is an urgent need to clarify clinical features and risk factors different from another GI tract malignancy to implement specific screening and management strategies. Especially, in this Special Issue, we would like to deal with the management of relatively rare conditions of CRC such as obstructive colon and rectal cancer, lateral pelvic lymph node metastasis from rectal cancer, early-onset (young age) CRC, and quality of life in CRC survivorships.
In this Special Issue, review articles with a focus on the molecular biology, biomarkers, clinicopathologic characteristics, risk factors, and treatment strategies are invited.
Dr. Bong-hyeon Kye
Dr. Ri Na Yoo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- obstructive colon and rectal cancer
- lateral pelvic lymph node
- early-onset colorectal cancer
- CRC survivorship